BioPace

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBioPace
Drug Alias Namesino-atrial node cell therapy (Bioheart)sino-atrial node cell therapy (Bioheart)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAtrial Fibrillation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioPace Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioPace Inc
Active IndicationsN/A
Inactive IndicationsAtrial Fibrillation

Other Information

ATC CodeN/A
Related LinksN/A